Bio-Rad Laboratories (BIO) Tax Provisions (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Tax Provisions data on file, last reported at -$162.7 million in Q1 2026.

• On a quarterly basis, Tax Provisions fell 938.66% year-over-year to -$162.7 million in Q1 2026; TTM through Mar 2026 was $53.5 million, a 109.13% increase from a year earlier, with the FY2025 full-year figure at $235.6 million, up 147.28% from the prior year.
• Tax Provisions for Q1 2026 stood at -$162.7 million, down from $209.2 million in the prior quarter.
• Over the last five years, Tax Provisions for BIO reached as high as $263.6 million in Q4 2022 and fell as low as -$1.0 billion in Q1 2022.
• Historically, Tax Provisions has averaged -$100.9 million across 5 years, with a median of $15.9 million in 2023.
• Across the five-year window, Tax Provisions soared 575.64% in 2024 and sank 938.66% in 2026, its largest moves.
• Year by year, Tax Provisions stood at $263.6 million in 2022, then tumbled by 70.16% to $78.7 million in 2023, then plunged by 345.47% to -$193.1 million in 2024, then surged by 208.34% to $209.2 million in 2025, then slumped by 177.77% to -$162.7 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were -$162.7 million in Q1 2026, $209.2 million in Q4 2025, and -$89.2 million in Q3 2025.